Recent stories
-
A Non-Myeloablative Allogeneic Transplant Becomes the Ultimate ImmunoTherapy
While the graft-versus-cancer effect is highly desirable after allogeneic transplant, the toxicities associated with high dose chemotherapy/radiation during the conditioning regimen have been a barrier.
-
Precision Medicine: Applying Cutting-Edge Technology to Patient Care
One of the challenges to monitor disease status in hematologic malignancies after a curative treatment such as transplant is the lack of a patient-specific and sensitive test.
-
Cellular Therapeutics: Release the Power of Individual Cellular Component
While the role for the individual cell population of the donor graft is not fully understood after allogeneic transplant, recent works in the field have yielded some interesting observations which may lead to advances in clinical care.
-
Clinical Story: It Takes a Village to Cure a Cancer
When someone has mycosis fungoides, malignant cells in the blood travel to the skin, causing lesions that appear as an itchy rash.
BMT Update
The BMT Update is produced twice a year to showcase the exciting advances our program is making in the fields of Blood and Marrow Transplantation and Cellular Therapies.
If you would like to sign up to receive the newsletter, please email us at sdoran@stanfordhealthcare.org. Alternately, you can call us at (650) 723-0822.